Cytiva is expanding its Xcellerex X-platform portfolio with the addition of 500L and 2,000L bioreactors.

In this case study, analytical method optimization with Fusion QbD software for a synthetic peptide and small molecule API is ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

Merck will manufacture and commercialize HRS-5346 worldwide.

BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.

The launch of Denarase High Salt GMP-grade marks a significant milestone in c-LEcta’s commitment to providing innovative solutions for the biopharmaceutical industry. This engineered enzyme ...

Carbogen Amcis has been granted a GMP certificate for its 9,500m² Saint-Beauzire facility, supporting a wide range of ...

Likarda has received a grant from the Gates Foundation that supports its proprietary Core-Shell Spherification (CSS) system.

Announced in December 2024, David Enloe joins as the division’s CEO. He has experience leading life science CDMOs such as ...

Co., Ltd. have entered into an exclusive license agreement for UBT251 for the treatment of obesity, type 2 diabetes, and other diseases.

The FDA has cleared Everest Medicines’ Investigational New Drug (IND) application for EVM14, a Tumor-Associated Antigen (TAA) ...

Pathios Therapeutics Limited, a biotech company, has appointed Sumeet Ambarkhane, M.D., as Chief Medical Officer (CMO).